Promising MSF Research Highlights Immense Benefits, Need for Expanded Use of DR-TB Drug Combination

Press releasePromising MSF Research Highlights Immense Benefits, Need for Expanded Use of DR-TB Drug CombinationFebruary 14, 2018NEW YORK, FEBRUARY 14, 2018—New research published today inThe Lancet Infectious Diseases journal by the international medical humanitarian organization Doctors Without Borders/M édecins Sans Frontières (MSF) provides strong evidence that a combination of two new drugs fortuberculosis (TB) —the world’s leading infectious disease killer—could be used to treat drug-resistant (DR-TB) fo

Source: MSF News - February 13, 2018 Category: International Medicine & Public Health Authors: Brienne Prusak Source Type: news